tiprankstipranks
Kronos Bio provides update on review of strategic alternatives
PremiumThe FlyKronos Bio provides update on review of strategic alternatives
3M ago
Piper downgrades Kronos Bio on istisociclib discontinuation
Premium
The Fly
Piper downgrades Kronos Bio on istisociclib discontinuation
3M ago
Kronos Bio downgraded to Hold from Buy at TD Cowen
Premium
The Fly
Kronos Bio downgraded to Hold from Buy at TD Cowen
3M ago
KRON Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsKRON Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
Kronos Bio announces preclinical data from p300 KAT inhibitor program
Premium
The Fly
Kronos Bio announces preclinical data from p300 KAT inhibitor program
4M ago
Kronos Bio to present data from p300 KAT inhibitor program
Premium
The Fly
Kronos Bio to present data from p300 KAT inhibitor program
4M ago
Kronos Bio:1st patient dosed in expansion cohort with KB-0742 for HGSOC
PremiumThe FlyKronos Bio:1st patient dosed in expansion cohort with KB-0742 for HGSOC
7M ago
Kronos Bio appoints Deborah Knobelman as COO, CFO
Premium
The Fly
Kronos Bio appoints Deborah Knobelman as COO, CFO
9M ago
Kronos Bio reports Q1 EPS (50c), consensus (42c)
Premium
The Fly
Kronos Bio reports Q1 EPS (50c), consensus (42c)
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100